Knigge Society is an etiquette group aimed to advise people on etiquette as well as social behavior in Germany.
The group has hailed for a strict ban on kissing, particularly in the workplace and cited that practice of greeting colleagues and business partners with a kiss on the cheek is uncomfortable for many Germans therefore cannot be considered as usual act.
While commenting on the issue, the Chairman of the Society, Hans-Michael Klein, has claimed to acknowledge a number of mails from workers on the issue, seeking advice to deal with such situation.
“It has come from places like Italy, France and South America, and belongs in a specific cultural context. We don’t like it, they say”, added Hans-Michael Klein. “Most people said they didn’t like it. They feel there is somehow an erotic aspect to it – a form of body contact which can be used by men to get close to a woman”.
The society organized a meeting to discuss the issue and conducted a survey on street and at their seminar to know their opinion.
Consequently, it suggested people to practice their traditional handshake at a 60 cm distance from one another. The group has more than 500 members.
According to software giant Microsoft, the company’s Edge browser — the default browser included in the Windows 10 OS — consumes less battery as compared to any of the other browsers.
Touting the power-saving capabilities of its Edge…
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies…
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle…
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the…
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in…
Tech giant Google has officially acknowledged the widely-known fact that Android’s update system…
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won’t seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said…
In a Tuesday announcement, Adobe revealed that it has...
With the computer business having witnessed steep losses...
In a scenario where the government of the nations are...
After the event that was the 'hot-news' of the week, the...
© 2024 AustrianTribune